Novartis AG (NVS) Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies Transcript

PresentationOperator Good morning and good afternoon, and welcome to the Novartis Immunology Portfolio Update Conference Call and Live Webcast. [Operator Instructions] The conference is being recorded. [Operator Instructions] A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. With that, I would like to hand over to Ms. Isabella Zinck, Investor Relations. Please go ahead, madam. ...